Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-18

Clinical Trial Update: A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis [Phase 4]

View source ↗

Summary

A multi-center Phase 4 study evaluated short- and long-term use of Protopic ointment (tacrolimus) for atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Protopic Ointment (tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Dermatitis, Atopic | Phase 4 | Status: COMPLETED